Page 1028 - Williams Hematology ( PDFDrive )

1002 Part VII: Neutrophils, Eosinophils, Basophils, and Mast Cells Chapter 65: Neutropenia and Neutrophilia 1003

69. Annabi B, Hiraiwa H, Mansfield BC, et al: The gene for glycogen-storage disease type 108. Nossent JC, Swaak AJ: Prevalence and significance of haematological abnormalities in
1b maps to chromosome 11q23. Am J Hum Genet 62:400, 1998. patients with systemic lupus erythematosus. Q J Med 80:605, 1991.
70. Visser G, Rake JP, Fernandes J, et al: Neutropenia, neutrophil dysfunction, and inflam- 109. Bowman SJ: Hematological manifestations of rheumatoid arthritis. Scand J Rheumatol
matory bowel disease in glycogen storage disease type Ib: Results of the European Study 31:251, 2002.
on Glycogen Storage Disease type I. J Pediatr 13:187, 2000. 110. Starkebaum G: Chronic neutropenia associated with autoimmune disease. Semin
71. Schroten H, Wendel U, Burdach S, et al: Colony-stimulating factors for neutropenia in Hematol 39:121, 2002.
glycogen storage disease Ib. Lancet 337:736, 1991. 111. Martinez-Baños D, Crispin JC, Lazo-Langner A, Sánchez-Guerror J: Moderate and
72. Schroeder T, Hildebrandt B, Mayatepek E, et al: A patient with glycogen storage dis- severe neutropenia in patients with systemic lupus erythematosus. Rheumatology
ease type Ib presenting with acute myeloid leukemia (AML) bearing monosomy 45:994, 2006.
7 and translocation t(3;8)(q26;q24) after 14 years of treatment with granulocyte colony- 112. Campion G, Maddison PJ, Goulding N, et al: The Felty syndrome: A case-matched
stimulating factor (G-CSF): A case report. J Med Case Reports 2:319, 2008. study of clinical manifestations and outcome, serologic features, and immunogenetic
73. Dale DC, Bolyard AA, Aprikyan A: Cyclic neutropenia. Semin Hematol 39:89, 2002. associations. Medicine (Baltimore) 69:69, 1990.
74. Horwitz M, Benson KF, Person RE, et al: Mutations in ELA2, encoding neutrophil elas- 113. Liu JH, Wei S, Lamy T, Epling-Burnette PK, et al: Chronic neutropenia mediated by Fas
tase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 23:433, 1999. ligand. Blood 95:3219, 2000.
75. Palmer SE, Stephens K, Dale DC: Genetics, phenotype, and natural history of autoso- 114. Starkebaum G, Dancey JT, Arend WP: Chronic neutropenia: Possible association with
mal dominant cyclic hematopoiesis. Am J Med Genet 66:413, 1996. Sjögren’s syndrome. J Rheumatol 8:679, 1981.
76. Dale DC, Hammond WP IV: Cyclic neutropenia: A clinical review. Blood Rev 2:178, 115. Coppo P, Sibilia J, Maloisel F, et al: Primary Sjögren’s syndrome associated agranulocy-
1998. tosis: A benign disorder? Ann Rheum Dis 62:476, 2003.
77. Makaryan V, Zeidler C, Bolyard AA, et al: The diversity of mutations and clinical out- 116. Chandra PA, Margulis Y, Schiff C: Rituximab is useful in the treatment of Felty’s syn-
comes for ELANE-associated neutropenia. Curr Opin Hematol 22:3-11,2015. drome. Am J Ther 15:321, 2008.
78. Hammond WP IV, Price TH, Souza LM, Dale DC: Treatment of cyclic neutropenia with 117. Patel AM, Moreland LW: Tocilizumab versus methotrexate in moderate to severe rheu-
granulocyte colony-stimulating factor. N Engl J Med 320:1306, 1989. matoid arthritis. Curr Rheumatol Rep 11:313, 2009.
79. Fowler B: Genetic defects of folate and cobalamin metabolism. Eur J Pediatr 157:S60, 118. Wiseman BK, Doan CA: A newly recognized granulopenic syndrome caused by
1998. excessive splenic leukolysis and successfully treated by splenectomy. Ann Intern Med
80. Monagle PT, Tauro GP: Long-term follow up of patients with transcobalamin II defi- 16:1097, 1942.
ciency. Arch Dis Child 72:237, 1995. 119. Kracke RR: Relation of drug therapy to neutropenic states. JAMA 111:1255, 1938.
81. Quadros, EV. Advances in the understanding of cobalamin assimilation and metabo- 120. Wassenberg S, Herborn G, Rau R: Methotrexate treatment in Felty’s syndrome. Br J
lism. Br J Haematol 148:195, 2010. Rheumatol 37:908, 1998.
82. Dale DC, Guerry D 4th, Wewerka JR, et al: Chronic neutropenia. Medicine (Baltimore) 121. Hellmich B, Schnabel A, Gross WL: Treatment of severe neutropenia due to Felty’s
58:128, 1979. syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor.
83. Juul SE, Haynes JW, McPherson RJ: Evaluation of neutropenia and neutrophilia in hos- Semin Arthritis Rheum 29:82, 1999.
pitalized preterm infants. J Perinatol 24:150, 2004. 122. Rashba EJ, Rowe JM, Packman CH: Treatment of the neutropenia of Felty syndrome.
84. James RM, Kinsey SE: The investigation and management of chronic neutropenia in Blood Rev 10:177, 1996.
children. Arch Dis Child 91:852, 2006. 123. Bowman SJ, Geddes GC, Corrigall V, et al: Large granular lymphocyte expansions in
85. Juul SE, Christensen RD: Effect of recombinant granulocyte colony-stimulating factor Felty’s syndrome have an unusual phenotype of activated CD45RA+ cells. Br J Rheuma-
on blood neutrophil concentrations among patients with “idiopathic neonatal neutro- tol 35:1252, 1996.
penia”: A randomized, placebo-controlled trial. J Perinatol 23:493, 2003. 124. van Staa TP, Boulton F, Cooper C, et al: Neutropenia and agranulocytosis in England
86. Percival SS: Neutropenia caused by copper deficiency: Possible mechanisms of action. and Wales: Incidence and risk factors. Am J Hematol 72:248, 2003.
Nutr Rev 53:59, 1999. 125. Andres E, Noel E, Kurtz JE, et al: Life-threatening idiosyncratic drug-induced agranu-
87. Olivares M, Uauy R: Copper as an essential nutrient. Am J Clin Nutr 63:791S, 1996. locytosis in elderly patients. Drugs Aging 21:427, 2004.
88. Gregg XT, Reddy V, Prchal JT: Copper deficiency masquerading as myelodysplastic 126. Andrès E, Maloisel F: Idiosyncratic drug-induced agranulocytosis or acute neutrope-
syndrome. Blood 100:1493, 2002. nia. Curr Opin Hematol 15:15, 2008.
89. Levitt LJ: Chlorpropamide-induced pure white cell aplasia. Blood 69:394, 1987. 127. Curtis BR: Drug-induced immune neutropenia/agranulocytosis. Immunohematology
90. Kyle RA: Natural history of chronic idiopathic neutropenia. N Engl J Med 302:908, 1980. 30:95, 2014.
91. Palmblad JE, von dem Borne AE: Idiopathic, immune, infectious, and idiosyncratic 128. Khan AA, Harvey J, Sengupta S. Continuing clozapine with granulocyte colony-
neutropenias. Semin Hematol 39:113, 2002. stimulating factor in patients with neutropenia. Ther Adv Psychopharmacol 3:266, 2013.
92. Papadaki HA, Palmblad J, Eliopoulos GD: Non-immune chronic idiopathic neutrope- 129. Schulz W: Ueber digenartige Halserkrankungen. Dtsch Med Wochenschr 48:1495, 1922.
nia of adult: An overview. Eur J Haematol 67:35, 2001. 130. Uetreicht JP: Reactive metabolites and agranulocytosis. Eur J Haematol Suppl 60:33, 1996.
93. Price TH, Lee MY, Dale DC, Finch CA: Neutrophil kinetics in chronic neutropenia. 131. Claas FH: Immune mechanisms leading to drug-induced blood dyscrasias. Eur J Hae-
Blood 54:581, 1979. matol Suppl 60:64, 1996.
94. Logue GL, Shastri KA, Laughlin M, et al: Idiopathic neutropenia: Antineutrophil anti- 132. Carey PJ: Drug-induced myelosuppression: Diagnosis and management. Drug Saf
bodies and clinical correlations. Am J Med 90:211, 1991. 26:691, 2003.
95. Palmblad J, Papadaki HA: Chronic idiopathic neutropenias and severe congenital neu- 133. Mauri MC, Rudelli R, Bravin S, et al: Clozapine metabolism rate as a possible index of
tropenia. Curr Opin Hematol 15:8, 2008. drug induced granulocytopenia. Psychopharmacology (Berl) 35:459, 1998.
96. Matsuyama W, Yamamoto M, Higashimoto I, et al: TNF-related apoptosis-inducing 134. Garrey WE, Bryan WR: Variations in white blood cell counts. Physiol Rev 15:597, 1935.
ligand is involved in neutropenia of systemic lupus erythematosus. Blood 104:184, 135. Dancey JT, Deubelbeiss KA, Harker LA, Finch CA: Neutrophil kinetics in man. J Clin
2004. Invest 58:705, 1976.
97. Dale DC, Bonilla MA, Davis MW, et al: A randomized controlled phase III trial of 136. Quindry JC, Stone WL, King J, Broeder CE: The effects of acute exercise on neutrophils
recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment and plasma oxidative stress. Med Sci Sports Exerc 35:1139, 2003.
of severe chronic neutropenia. Blood 81:2496, 1993. 137. Benschop RJ, Rodriquez-Feuerhahn M, Schedlowski M: Catecholamine-induced leu-
98. Lalezari P, Radel E: Neutrophil-specific antigens: Immunology and clinical significance. kocytosis: Early observations, current research, and future directions. Brain Behav
Semin Hematol 11:281, 1974. Immun 10:77, 1996.
99. Bux J: Molecular nature of antigens implicated in immune neutropenias. Int J Hematol 138. Toft P, Helbo-Hansen HS, Tonnesen E, et al: Redistribution of granulocytes during
76(Suppl 1):399, 2002. adrenaline infusion and following administration of cortisol in healthy volunteers. Acta
100. Stroncek D: Neutrophil alloantigens. Transfus Med Rev 16:67, 2002. Anaesthesiol Scand 38:254, 1994.
101. Bux J: Human neutrophil alloantigens. Vox Sang 94:277, 2008. 139. Dale DC, Fauci, AS, Gerry D IV, Wolff SM: Comparison of agents producing neu-
102. Maheshwari A, Christensen RD, Calhoun DA: Immune neutropenia in the neonate. trophilic leukocytosis in man. J Clin Invest 56:808, 1975.
Adv Pediatr 49:317, 2002. 140. Price TH, Chatta GS, Dale DC: The effect of recombinant granulocyte-colony stimulat-
103. Puig N, de Haas M, Kleijer M, et al: Isoimmune neonatal neutropenia caused by Fc ing factor on neutrophil kinetics in normal young and elderly humans. Blood 88:335,
gamma RIIIb antibodies in a Spanish child. Transfusion 35:683, 1995. 1996.
104. Maslanka K, Guz K, Uhrynowska M, Zupanska B: Isoimmune neonatal neutropenia 141. Dale DC, Liles WC, Llewellyn C, Price TH: The effects of granulocyte macrophage
due to anti-Fc(gamma) RIIIb antibody in a mother with an Fc(gamma) RIIIb defi- colony stimulating factor (GM-CSF) on neutrophil kinetics and function in normal
ciency. Transfus Med 11:111, 2001. human volunteers. Am J Hematol 57:7, 1998.
105. Maheshwari A, Christensen RD, Calhoun DA: Immune-mediated neutropenia in the 142. Reding MT, Hibbs JR, Morrison VA, et al: Diagnosis and outcome of 100 consecutive
neonate. Acta Paediatr Suppl 91:98, 2002. patients with extreme granulocytic leukocytosis. Am J Med 104:12, 1998.
106. Taniuchi S, Masuda M, Hasui M, et al: Differential diagnosis and clinical course of 143. Etzioni A, Tonetti M: Leukocyte adhesion deficiency II—From A to almost Z. Immunol
autoimmune neutropenia in infancy: Comparison with congenital neutropenia. Acta Rev 178:138, 2000.
Paediatr 91:1179, 2002. 144. Bishop CR, Athens JW, Boggs DR, et al: Leukokinetic studies: XIII. A non-steady state
107. Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neu- kinetic evaluation of the mechanism of cortisone-induced granulocytosis. J Clin Invest
tropenia in infancy: Analysis of 240 cases. Blood 91:181, 1998. 47:249, 1968.

Kaushansky_chapter 65_p0991-1004.indd 1003 9/17/15 6:44 PM